MX359316B - Metodo de administracion de un tensioactivo pulmonar. - Google Patents

Metodo de administracion de un tensioactivo pulmonar.

Info

Publication number
MX359316B
MX359316B MX2013006282A MX2013006282A MX359316B MX 359316 B MX359316 B MX 359316B MX 2013006282 A MX2013006282 A MX 2013006282A MX 2013006282 A MX2013006282 A MX 2013006282A MX 359316 B MX359316 B MX 359316B
Authority
MX
Mexico
Prior art keywords
administration
pulmonary surfactant
infant
treating
treatment
Prior art date
Application number
MX2013006282A
Other languages
English (en)
Inventor
Chiesi Paolo
Herting Egbert
Gopel Wolfgang
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MX359316B publication Critical patent/MX359316B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con un método para el tratamiento de dificultad respiratoria en un niño con necesidad de tal tratamiento, el método comprende la administración intratraqueal de un tensioactivo pulmonar mediante un tubo delgado.
MX2013006282A 2007-06-08 2008-05-23 Metodo de administracion de un tensioactivo pulmonar. MX359316B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/811,351 US8048043B2 (en) 2007-06-08 2007-06-08 Method of administration of a pulmonary surfactant
PCT/EP2008/004120 WO2008148469A1 (en) 2007-06-08 2008-05-23 A method of administration of a pulmonary surfactant

Publications (1)

Publication Number Publication Date
MX359316B true MX359316B (es) 2018-09-25

Family

ID=39832595

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013006282A MX359316B (es) 2007-06-08 2008-05-23 Metodo de administracion de un tensioactivo pulmonar.
MX2009012835A MX2009012835A (es) 2007-06-08 2008-05-23 Metodo de administracion de un tensioactivo pulmonar.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009012835A MX2009012835A (es) 2007-06-08 2008-05-23 Metodo de administracion de un tensioactivo pulmonar.

Country Status (23)

Country Link
US (2) US8048043B2 (es)
EP (2) EP2164504B1 (es)
JP (1) JP5490683B2 (es)
KR (2) KR101344159B1 (es)
CN (1) CN101765431B (es)
AU (1) AU2008258872B2 (es)
BR (1) BRPI0811387B8 (es)
CA (1) CA2690097C (es)
CY (2) CY1116680T1 (es)
DK (2) DK2164504T3 (es)
EA (1) EA016308B1 (es)
ES (2) ES2547489T3 (es)
HK (1) HK1141457A1 (es)
HR (2) HRP20150966T1 (es)
HU (2) HUE025957T2 (es)
LT (1) LT2719391T (es)
ME (1) ME02327B (es)
MX (2) MX359316B (es)
PL (2) PL2164504T3 (es)
PT (2) PT2719391T (es)
RS (2) RS54196B1 (es)
SI (2) SI2164504T1 (es)
WO (1) WO2008148469A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475373B1 (en) * 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
RU2504395C1 (ru) * 2012-07-13 2014-01-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ/ФГБУ "РНЦРХТ" Минздравсоцразвития России Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении
ITMI20150033U1 (it) * 2015-02-13 2016-08-13 Chiesi Farm Spa Catetere per la somministrazione di un surfattante polmonare
EP3277351B1 (en) 2015-04-02 2019-06-05 Hill-Rom Services PTE. LTD. Manifold for respiratory device
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
MA46605A (fr) 2016-10-26 2021-06-02 Chiesi Farm Spa Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
JP2020502242A (ja) 2016-12-22 2020-01-23 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 進行性のｂｐｄの処置のための肺サーファクタント及びステロイドを含む処置的組み合わせ物
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
MA54367A (fr) 2018-12-06 2021-11-10 Chiesi Farm Spa Dispositif de contrôle des voies aériennes à masque laryngé et procédé d'administration d'un médicament à travers un dispositif de contrôle des voies aériennes à masque laryngé
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
AU2022306466A1 (en) * 2021-07-05 2024-02-15 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant
CN115634199B (zh) * 2022-10-18 2024-05-03 杭州汉库医药科技有限公司 一种混悬型肺表面活性物质注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
GB9524007D0 (en) * 1995-11-23 1996-01-24 Bangham Alec D Endotrachael tubes with pulmonary medicaments
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2003035679A2 (en) * 2001-10-25 2003-05-01 Medical Research Council Molecules
EP1897577B1 (de) * 2002-08-02 2012-05-16 Med In Medical Innovations GmbH Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdrucks (CPAP-Vorrichtung)
US20060040860A1 (en) * 2004-06-17 2006-02-23 Mario Ruediger Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
US20060112961A1 (en) * 2004-11-29 2006-06-01 Hany Aly Pediatric mask, especially suited for premature infants
ES2380046T3 (es) * 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar

Also Published As

Publication number Publication date
EP2719391B1 (en) 2016-11-30
US20120017896A1 (en) 2012-01-26
KR101399738B1 (ko) 2014-05-27
AU2008258872B2 (en) 2012-10-04
KR101344159B1 (ko) 2013-12-23
HK1141457A1 (en) 2010-11-12
CN101765431B (zh) 2013-04-03
HRP20170270T1 (hr) 2017-04-21
KR20100028530A (ko) 2010-03-12
RS55733B1 (sr) 2017-07-31
US8905979B2 (en) 2014-12-09
US20080305180A1 (en) 2008-12-11
PL2719391T3 (pl) 2017-06-30
EP2164504A1 (en) 2010-03-24
RS54196B1 (en) 2015-12-31
CA2690097C (en) 2018-05-22
JP2010528729A (ja) 2010-08-26
BRPI0811387B8 (pt) 2021-05-25
EA016308B1 (ru) 2012-04-30
KR20130038940A (ko) 2013-04-18
ES2616727T3 (es) 2017-06-14
SI2164504T1 (sl) 2015-10-30
ME02327B (me) 2016-06-20
PT2164504E (pt) 2015-10-16
DK2164504T3 (en) 2015-10-12
HRP20150966T1 (hr) 2015-10-09
WO2008148469A1 (en) 2008-12-11
BRPI0811387A2 (pt) 2015-07-21
EA200901499A1 (ru) 2010-06-30
CA2690097A1 (en) 2008-12-11
HUE031750T2 (en) 2017-07-28
BRPI0811387B1 (pt) 2018-11-06
PT2719391T (pt) 2017-03-02
AU2008258872A1 (en) 2008-12-11
PL2164504T3 (pl) 2016-01-29
DK2719391T3 (en) 2017-02-20
SI2719391T1 (sl) 2017-03-31
JP5490683B2 (ja) 2014-05-14
MX2009012835A (es) 2009-12-15
US8048043B2 (en) 2011-11-01
ES2547489T3 (es) 2015-10-06
CN101765431A (zh) 2010-06-30
HUE025957T2 (en) 2016-05-30
EP2164504B1 (en) 2015-07-29
CY1116680T1 (el) 2017-03-15
CY1118635T1 (el) 2017-07-12
EP2719391A1 (en) 2014-04-16
LT2719391T (lt) 2017-02-10

Similar Documents

Publication Publication Date Title
MX359316B (es) Metodo de administracion de un tensioactivo pulmonar.
AP2012006227A0 (en) Derivatives of purine or deazapurine useful for the treatment of inter, alia viral, infections.
WO2009065738A3 (de) Polyoxyalkylenamine zur verbesserten duftausbeute
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
IN2012KN02804A (es)
HRP20130558T1 (hr) Derivat 17-hidroksi-17-pentafluoretil-estra-4,9(10)-dien-11-arila, postupci za njegovu proizvodnju i njegova uporaba za lijeäśenje bolesti
UA103922C2 (ru) Обработанный табак, курительное изделие и способ изготовления обработанного табака для курительного изделия
PL2406803T3 (pl) Przycisk, sposób jego wytwarzania i medyczny element do manipulacji
MY171864A (en) Iron(iii) citrate, substantially free of beta-iron hydroxide oxide
MX2010004570A (es) Metodos para la produccion de sal.
WO2007081889A3 (en) Production of dolasetron
WO2009092052A3 (en) Methods and compositions for treating polyps
MX2009009490A (es) Profarmacos novedosos.
TW200833649A (en) Method for the preparation of hydroxyadamantanamine
SI2413933T2 (sl) 2,4,6-triufloro-n-(6-(1-metil-piperidin-4-karbonil)-piridin-2-il)- benzamid za tretiranje migrene preko oralne ali intravenske poti
MY155829A (en) Pyrazole derivatives, preparation thereof and therapeutic use thereof
MX2013011772A (es) Aclidinio para uso en la mejora de la calidad del sueño en pacientes respiratorios.
MX360235B (es) Composicion para evitar o tratar osteoporosis y metodo de manufactura para el mismo.
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
PH12014501367A1 (en) Processes for making magnolol and derivatives thereof
WO2010112589A3 (de) Schnittschablone aus keramik
SI2454266T1 (sl) Citratna sol 9e-15-(2-pirolidin-1-il-etoksi)-7,12,25-trioksa-19,21,24-triaza-tetra- ciklo (18.3.1.1(2,5).1(14)18)heksakosa-1(24),2,4,9,14,16,18(26),20,22- nonaena
MY169933A (en) New compositions
MX2009006748A (es) Proceso para la preparacion y aislamiento de los estereoisomeros individuales de fenilciclopentan-carboxilatos 3-sustituidos de 1-amino.
MX2013004862A (es) Metodo de uso de gas de oxido nitrico inhalado para el tratamiento del sindrome de disfuncion respiratoria aguda.